Valvular Heart Disease - developinganaesthesia

MSAC agreed that patient eligibility for TAVI via transfemoral delivery should be determined by evaluating symptoms such as chest pain, dyspnoea, syncope; using an echocardiogram to demonstrate severe aortic stenosis; assessing whether the patient is deemed high operative risk or inoperable; assessing whether the patient has suitable anatomy (aortic size and route); and … ................
................